{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:21Z","timestamp":1790223441283,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.lfs.2025.123945","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:13:55Z","timestamp":1756437235000},"page":"123945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The role of ferroptosis in doxorubicin-induced cardiotoxicity \u2013 An update"],"prefix":"10.1016","volume":"380","author":[{"given":"Pammi","family":"Bhadra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prisha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini Topinar","family":"Hanumantharayudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankarganesh","family":"Arunachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.lfs.2025.123945_bb0005","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2174\/092986709788803312","article-title":"Doxorubicin: the good, the bad and the ugly effect","volume":"16","author":"Carvalho","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"23","key":"10.1016\/j.lfs.2025.123945_bb0010","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","article-title":"Long-term Enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood Cancer","volume":"20","author":"Lipshultz","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.lfs.2025.123945_bb0015","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1200\/JCO.2007.14.9401","article-title":"Anthracycline cardiotoxicity: from bench to bedside","volume":"26","author":"Gianni","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0020","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2025.123945_bb0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","article-title":"Oxidative stress injury in doxorubicin-induced cardiotoxicity","volume":"307","author":"Songbo","year":"2019","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2020.09.035","article-title":"Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress","volume":"533","author":"Zhao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0035","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00018-020-03729-y","article-title":"Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways","volume":"78","author":"Wang(a)","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.lfs.2025.123945_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172803","article-title":"Doxorubicin-induced oxidative stress: the protective effect of nicorandil on HL-1 cardiomyocytes","volume":"12","author":"Asensio-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0045","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2025.123945_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043344","article-title":"Ferritinophagy, a form of autophagic ferroptosis: new insights into cancer treatment","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s10565-024-09853-w","article-title":"Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future","volume":"40","author":"Fang","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"9","key":"10.1016\/j.lfs.2025.123945_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.lfs.2025.123945_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091291","article-title":"Lipid peroxidation and antioxidant protection","volume":"13","author":"Valgimigli","year":"2023","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.lfs.2025.123945_bb0070","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1016\/S0021-9258(18)98591-1","article-title":"Perhydroxyl radical (HOO.) initiated lipid peroxidation. The role of fatty acid hydroperoxides","volume":"266","author":"Aikens","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2025.123945_bb0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3177\/jnsv.38.Special_548","article-title":"S-19-4 the mode of action of lipid-soluble antioxidants in biological membranes. relationship between the effects of ubiquinol and vitamin E as inhibitors of lipid peroxidation in submitochondrial particles","volume":"38","author":"Ernster","year":"1992","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"issue":"5880","key":"10.1016\/j.lfs.2025.123945_bb0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1126\/science.1157643","article-title":"A cytosolic iron chaperone that delivers iron to ferritin","volume":"320","author":"Shi","year":"2008","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0085","first-page":"369","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death & Differ. 2016 23:3"},{"issue":"9","key":"10.1016\/j.lfs.2025.123945_bb0090","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/ijc.22079","article-title":"Expression of the hemochromatosis gene modulates the cytotoxicity of doxorubicin in breast cancer cells","volume":"119","author":"Chitambar","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/jpi.12176","article-title":"Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin","volume":"57","author":"Govender","year":"2014","journal-title":"J. Pineal Res."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0100","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.133","article-title":"Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells","volume":"8","author":"Basit","year":"2017","journal-title":"Cell Death Dis."},{"issue":"4\u20135\u20136","key":"10.1016\/j.lfs.2025.123945_bb0110","first-page":"367","article-title":"Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species","volume":"7","author":"Hanson","year":"2018","journal-title":"Gene Expr."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1096\/fasebj.12.7.541","article-title":"The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase\/iron regulatory protein-1 in cytosolic fractions from human myocardium","volume":"12","author":"Minotti","year":"1998","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0120","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00109-006-0068-y","article-title":"IRP1-independent alterations of cardiac iron metabolism in doxorubicin-treated mice","volume":"84","author":"Corna","year":"2006","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.lfs.2025.123945_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-Hydroxy-2-Nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"22","key":"10.1016\/j.lfs.2025.123945_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.lfs.2025.123945_bb0135","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.lfs.2025.123945_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1152\/physiolgenomics.00041.2017","article-title":"Nrf2 at the heart of oxidative stress and cardiac protection","volume":"50","author":"Chen","year":"2018","journal-title":"Physiol. Genomics"},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0145","first-page":"1","article-title":"Nrf2: a dark horse in doxorubicin-induced cardiotoxicity","volume":"9","author":"Zhao","year":"2023","journal-title":"Cell Death Discov. 2023 9:1"},{"issue":"MAY","key":"10.1016\/j.lfs.2025.123945_bb0150","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2025.123945_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101207","article-title":"Novel target for treating Alzheimer\u2019s diseases: crosstalk between the Nrf2 pathway and autophagy","volume":"65","author":"Zhang","year":"2021","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0160","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1080\/21655979.2022.2036895","article-title":"Propofol protects cardiomyocytes from doxorubicin-induced toxic injury by activating the nuclear factor erythroid 2-related factor 2\/glutathione peroxidase four signaling pathways","volume":"13","author":"Lu","year":"2022","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0165","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11010-021-04112-6","article-title":"Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling","volume":"476","author":"Luo","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.lfs.2025.123945_bb0170","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41418-022-00990-5","article-title":"PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2\/GPX4 pathway","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.taap.2013.10.023","article-title":"Keap1 redox-dependent regulation of doxorubicin-induced oxidative stress response in cardiac myoblasts","volume":"274","author":"Nordgren","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2025.123945_bb0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/FJC.0000000000000692","article-title":"Curdione ameliorated doxorubicin-induced cardiotoxicity through suppressing oxidative stress and activating Nrf2\/HO-1 pathway","volume":"74","author":"Wu","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0185","doi-asserted-by":"crossref","first-page":"7975","DOI":"10.1080\/21655979.2021.1985299","article-title":"Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor-like two and Sirtuin 2 signaling pathways","volume":"12","author":"Deng","year":"2021","journal-title":"Bioengineered"},{"issue":"6","key":"10.1016\/j.lfs.2025.123945_bb0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12012-020-09581-7","article-title":"Disruption of the Keap1\/Nrf2-antioxidant response system after chronic doxorubicin exposure in vivo","volume":"20","author":"Nordgren","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0195","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Volume 37","key":"10.1016\/j.lfs.2025.123945_bb0200","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pharmtox.37.1.517","article-title":"The heme oxygenase system: a regulator of second messenger gases","volume":"37","author":"Maines","year":"1997","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0205","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1152\/physrev.00003.2016","article-title":"Heme oxygenases in cardiovascular health and disease","volume":"96","author":"Ayer","year":"2016","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2025.123945_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113888","article-title":"Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1","volume":"175","author":"Sun","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2025.123945_bb0220","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.yjmcc.2017.10.008","article-title":"CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1","volume":"114","author":"Yuan","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.lfs.2025.123945_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943321","article-title":"Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism","volume":"13","author":"Cui","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123945_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.808480","article-title":"Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting Ferroptosis through SIRT1\/Nrf2 signaling pathway activation","volume":"12","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2025.123945_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.65","article-title":"Nrf2-keap1 pathway promotes cell proliferation and diminishes ferroptosis","volume":"6","author":"Fan","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.lfs.2025.123945_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110469","article-title":"Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2\/Keap1 pathway","volume":"377","author":"Wang","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"25","key":"10.1016\/j.lfs.2025.123945_bb0245","article-title":"Neuraminidase 1 exacerbated glycolytic dysregulation and cardiotoxicity by destabilizing SIRT1 through interactions with NRF2 and HIF1\u03b1","volume":"12","author":"Gao","year":"2025","journal-title":"Adv. Sci. (Weinh.)."},{"key":"10.1016\/j.lfs.2025.123945_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.850340","article-title":"Emerging roles of SIRT3 in cardiac metabolism","volume":"9","author":"Murugasamy","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"17","key":"10.1016\/j.lfs.2025.123945_bb0255","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1074\/jbc.M114.607960","article-title":"Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes","volume":"290","author":"Cheung","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2025.123945_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-023-04877-7","article-title":"MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation","volume":"80","author":"Schirone","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2025.123945_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102679","article-title":"TRIM21 deficiency protects against atrial inflammation and remodeling post myocardial infarction by attenuating oxidative stress","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123945_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - roles in innate immunity and autoimmune disease","volume":"12","author":"Jones","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2025.123945_bb0275","first-page":"3315","article-title":"TRIM21 Promotes Oxidative Stress and Ferroptosis through the SQSTM1-NRF2-KEAP1 Axis to Increase the Titers of H5N1 Highly Pathogenic Avian Influenza Virus","volume":"25","author":"Wei","year":"2024","journal-title":"Int. J. Mol. Sci. 2024, Vol. 25, Page 3315"},{"key":"10.1016\/j.lfs.2025.123945_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103456","article-title":"Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin","volume":"69","author":"Hou","year":"2021","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.lfs.2025.123945_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22011","article-title":"Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway","volume":"9","author":"Lin","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2025.123945_bb0290","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1512326","article-title":"miR-200a attenuated doxorubicin-induced cardiotoxicity through upregulation of Nrf2 in mice","volume":"2019","author":"Hu","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2025.123945_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150568","article-title":"Swimming training attenuates doxorubicin-induced cardiomyopathy by targeting the miR-17-3p\/KEAP1\/NRF2 axis","volume":"739","author":"Gao","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.123945_bb0300","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","article-title":"MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2","volume":"15","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2025.123945_bb0305","article-title":"Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2025.123945_bb0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid peroxidation and ferroptosis: the role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"11\u201312","key":"10.1016\/j.lfs.2025.123945_bb0315","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0320","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbrc.2019.10.085","article-title":"PRMT4 overexpression aggravates cardiac remodeling following myocardial infarction by promoting cardiomyocyte apoptosis","volume":"520","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0325","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2008.11.059","article-title":"Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs","volume":"378","author":"Ashley","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0330","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.lfs.2025.123945_bb0335","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1152\/ajpcell.00108.2006","article-title":"Tissue heterogeneity of the mammalian mitochondrial proteome","volume":"292","author":"Johnson","year":"2007","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-74718-1","article-title":"Novel approach to quantify mitochondrial content and intrinsic bioenergetic efficiency across organs","volume":"10","author":"McLaughlin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2025.123945_bb0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mito.2014.10.005","article-title":"Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity","volume":"20","author":"D\u2019Erchia","year":"2015","journal-title":"Mitochondrion"},{"issue":"758","key":"10.1016\/j.lfs.2025.123945_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8017","article-title":"Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis","volume":"15","author":"Abe","year":"2022","journal-title":"Sci. Signal."},{"issue":"6","key":"10.1016\/j.lfs.2025.123945_bb0360","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jacbts.2023.10.009","article-title":"Molecular mechanisms and therapeutic targeting of Ferroptosis in doxorubicin-induced cardiotoxicity","volume":"9","author":"Wu","year":"2024","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.lfs.2025.123945_bb0370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sbi.2017.05.011","article-title":"Readers, writers and erasers of N6-methylated adenosine modification","volume":"47","author":"Wu","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0375","first-page":"1","article-title":"Functions, mechanisms, and therapeutic implications of METTL14 in human cancer","volume":"15","author":"Guan","year":"2022","journal-title":"J. Hematol. Oncol. 2022 15:1"},{"issue":"3","key":"10.1016\/j.lfs.2025.123945_bb0380","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10565-021-09660-7","article-title":"METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis","volume":"39","author":"Zhuang","year":"2023","journal-title":"Cell Biol. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0385","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.bbrc.2018.06.168","article-title":"Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p\/ ABCC1 axis","volume":"503","author":"Hu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2025.123945_bb0390","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.freeradbiomed.2023.04.008","article-title":"Targeting the Na+\/K+ ATPase DR-region with DR-ab improves doxorubicin-induced cardiotoxicity","volume":"204","author":"Leng","year":"2023","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2025.123945_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1631\/jzus.B2300097","article-title":"Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases","volume":"25","author":"Luan","year":"2024","journal-title":"J. Zhejiang Univ. Sci. B 2024 25:1"},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0400","first-page":"493","article-title":"Uncovering the Cardioprotective Potential of Diacerein in Doxorubicin Cardiotoxicity: Mitigating Ferritinophagy-Mediated Ferroptosis via Upregulating NRF2\/SLC7A11\/GPX4 Axis","volume":"13","author":"El-Gohary","year":"2024","journal-title":"Antioxidants 2024, Vol. 13, Page 493"},{"key":"10.1016\/j.lfs.2025.123945_bb0405","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2023.06.025","article-title":"Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis","volume":"206","author":"He","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2025.123945_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118604","article-title":"Qishen granule alleviates doxorubicin-induced cardiotoxicity by suppressing ferroptosis via nuclear erythroid factor 2-related factor 2 (Nrf2) pathway","volume":"335","author":"Xue","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"43","key":"10.1016\/j.lfs.2025.123945_bb0415","article-title":"Biomimetic nanozymes target the heart to suppress ferroptosis for ameliorating doxorubicin-induced cardiotoxicity via synergetic effect of antioxidant stress and Nrf2\/Hmox1 inhibition","volume":"44","author":"Zhang","year":"2023","journal-title":"Eur. Heart J."},{"issue":"Pt A","key":"10.1016\/j.lfs.2025.123945_bb0420","article-title":"LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via activation of AKT\/SIRT3\/SOD2 signaling pathway","volume":"113","author":"Liu","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2025.123945_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/biom14040422","article-title":"Protective role of Dioscin against doxorubicin-induced chronic cardiotoxicity: insights from Nrf2-GPX4 axis-mediated cardiac ferroptosis","volume":"14","author":"Liu","year":"2024","journal-title":"Biomolecules"},{"issue":"Pt 1","key":"10.1016\/j.lfs.2025.123945_bb0430","doi-asserted-by":"crossref","first-page":"133792","DOI":"10.1016\/j.ijbiomac.2024.133792","article-title":"Fucoidan alleviates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the Nrf2\/GPX4 pathway","volume":"276","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2025.123945_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156670","article-title":"Higenamine protects against doxorubicin-induced heart failure by attenuating ferroptosis via modulating the Nrf2\/GPX4 signaling pathway","volume":"141","author":"Wen","year":"2025","journal-title":"Phytomedicine"},{"issue":"9","key":"10.1016\/j.lfs.2025.123945_bb0440","article-title":"NRF2, a superstar of ferroptosis","volume":"12","author":"Yan","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.lfs.2025.123945_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110412","article-title":"PRMT1 suppresses doxorubicin-induced cardiotoxicity by inhibiting endoplasmic reticulum stress","volume":"98","author":"Kim","year":"2022","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.lfs.2025.123945_bb0450","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525005806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525005806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:19:44Z","timestamp":1770916784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525005806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":87,"alternative-id":["S0024320525005806"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123945","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of ferroptosis in doxorubicin-induced cardiotoxicity \u2013 An update","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123945"}}